PMC Articles for MedGen (Select 1668743) - PMC

Select item 105291071.

A Phase 2 Study of Dasatinib in Recurrent Clear Cell Carcinoma of the Ovary, Fallopian Tube, Peritoneum or Endometrium: NRG Oncology/Gynecologic Oncology Group Study 0283

Roisin E. O’Cearbhaill, Austin Miller, Robert Soslow, Heather A. Lankes, Deborah DeLair, Sheila Segura, Shweta Chavan, Dmitriy Zamarin, Robert DeBernardo, Kathleen Moore, John Moroney, Mark Shahin, Premal H. Thaker, Andrea E. Wahner-Hendrickson, Carol Aghajanian

Gynecol Oncol. Author manuscript; available in PMC 2024 Sep 1.

Published in final edited form as: Gynecol Oncol. 2023 Sep; 176: 16–24. Published online 2023 Jul 5. doi: 10.1016/j.ygyno.2023.06.021

PMCID:: PMC10529107

Abstract Article PDF–1.6M

Select item 101967132.

Expression of Ferredoxin1 in cisplatin‑resistant ovarian cancer cells confers their resistance against ferroptosis induced by cisplatin

Ryosuke Takahashi, Koki Kamizaki, Keitaro Yamanaka, Yoshito Terai, Yasuhiro Minami

Oncol Rep. 2023 Jun; 49(6): 124. Published online 2023 May 5. doi: 10.3892/or.2023.8561

PMCID:: PMC10196713

Abstract Article PDF–4.1M

Select item 73661223.

Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first in class, proof-of-concept, single arm phase 2 study

Jung-Min Lee, Jayakumar Nair, Alexandra Zimmer, Stanley Lipkowitz, Christina M. Annunziata, Maria J. Merino, Elizabeth M. Swisher, Maria I. Harrell, Jane B. Trepel, Min-Jung Lee, Mohammad H. Bagheri, Dana-Adriana Botesteanu, Seth M. Steinberg, Lori Minasian, Irene Ekwede, Elise C. Kohn

Lancet Oncol. Author manuscript; available in PMC 2020 Jul 17.

Published in final edited form as: Lancet Oncol. 2018 Feb; 19(2): 207–215. Published online 2018 Jan 18. doi: 10.1016/S1470-2045(18)30009-3

PMCID:: PMC7366122

Abstract Article PDF–903K

Select item 68622964.

The Association and Significance of p53 in Gynecologic Cancers: The Potential of Targeted Therapy

Mitsuhiro Nakamura, Takeshi Obata, Takiko Daikoku, Hiroshi Fujiwara

Int J Mol Sci. 2019 Nov; 20(21): 5482. Published online 2019 Nov 4. doi: 10.3390/ijms20215482

PMCID:: PMC6862296

Abstract Article PDF–2.0M

Select item 27782185.

A PHASE II AND PHARMACODYNAMIC STUDY OF GEFITINIB IN PATIENTS WITH REFRACTORY OR RECURRENT EPITHELIAL OVARIAN CANCER

Edwin M. Posadas, Meghan S. Liel, Virginia Kwitkowski, Lori Minasian, Andrew K. Godwin, Mahrukh M. Hussain, Virginia Espina, Bradford J. Wood, Seth M. Steinberg, Elise C. Kohn

Cancer. Author manuscript; available in PMC 2009 Nov 17.

Published in final edited form as: Cancer. 2007 Apr 1; 109(7): 1323–1330. doi: 10.1002/cncr.22545

PMCID:: PMC2778218

Abstract Article PDF–463K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from MedGen

Items: 5

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity